Michael Courtney from Turku Bioscience received funding of 497 881 euros from The Academy of Finland. His research topic is “Temporally-encoded intracellular signalling and its impact on single cell integration…
University of Turku has awarded Title of Docent to Sami Ventelä and Santosh Lamichhane
The University of Turku, Department of Clinical Medicine has awarded the Title of Docent (Adjunct Professor) in Otorhinolaryngology to Senior Research Fellow and Affiliated Group Leader, MD Sami Ventelä and…
Turku Bioscience funding news
The first semester is ending and summer holidays are approaching. Our researchers have worked hard to secure funding for their research projects, and several of them were rewarded for their…
BioCity Student Symposium – REGISTRATION IS NOW OPEN!
This year BioCity Student Symposium titled Students are the Solution is arranged on-site by PhD researchers from The University of Turku and Abo Akademi University together with BioCity Turku and…
BioCity Turku Collaborative Research Funding Call 2022
BioCity Turku opens again a call for research funding for all BioCity Turku research groups. The funding is intended for new openings promoting research on emerging topics in molecular life sciences and…
New insights into regulation of immune response
The new study from Turku Bioscience provides new insights into how genetic variation associated with immune mediated diseases can influence T-cell function and regulation of immune response. The study was…
The Academy of Finland awarded Academy Research Fellow position to Alex Dickens and Academy postdoctoral researcher positions to Lili Li and Lea Mikkola
Three researchers at Turku Bioscience got funding from Academy of Finland September 2021 call. Alex Dickens received Academic Research Fellowship position and Lili Li and Lea Mikkola Postdoctoral researcher positions.
Doctoral defence: MSc Maria Jaakkola, May 6th 2022
Extracting information from gene expression data using computational methods Differences in the gene expression of samples from healthy and sick donors can be applied for many purposes, such as predicting…
Immunology Seminar Series, Sollid
Immunology Seminar May 3rd at 14:00 – 15:00 Virtual event Ludvig Sollid, Institute of Clinical Medicine and KG Jebsen Coeliac Disease Research Centre, University of Oslo and Department of…
Westermarck Lab: a study revealed a new subtype of drug-sensitive ovarian cancer
Professor Westermarck’s research team at Turku Bioscience has identified a possible new ovarian cancer subtype and shown that tumor cells modeling this subtype respond particularly well to an anticancer…